packageLinerixibat

linerixibat

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Linerixibat is an investigational bile acid inhibitor being studied for cholestatic itching associated with liver disease. It is not yet approved and remains under clinical investigation.

Summary written by glm-5.3-flash from Wikidata Q27256749 and the WHO ATC classification; not checked by a person.

name:linerixibat
ATC codes:A05AX08
DrugBank:DB11729
PubChem CID:53492727
Wikidata:Q27256749
formula:C28H38N2O7S
molar mass:546.679 g/mol (PubChem CID 53492727)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown